Strategic Partnerships BioSerenity's recent collaborations with neurodiagnostic leader Stratusneuro and partnerships with major financial backers like JOLT Capital and Dassault Systèmes indicate strong opportunities to offer advanced sensor technologies, IoT platforms, or AI-enabled diagnostic tools to enhance their current solutions.
Funding and Growth Having secured over 26 million dollars in recent funding rounds, primarily for developing wearable medical devices and digital solutions, BioSerenity is positioned for expansion into new markets and product lines, creating opportunities for scalable medical device and telehealth solution sales.
Focus on Digital Biomarkers The company's emphasis on leveraging physiological sensors, IoT, and AI to detect digital biomarkers suggests a demand for sophisticated data analytics and AI-driven diagnostics, presenting a sales avenue for advanced software platforms or data integration services.
Active Market Presence With collaborations involving over 200 hospitals across Europe and diagnosing over a hundred thousand patients annually, BioSerenity displays an extensive user base, ideal for expanding sales of medical sensors, wearable devices, and related maintenance or support services.
Innovative Technology Stack BioSerenity's adoption of cutting-edge technologies like textile-based sensors, cloud computing, and IoT indicates a readiness for innovative hardware and software solutions, creating potential sales opportunities in telemedicine, remote monitoring, and electronic health records integrations.
BioSerenity uses 8 technology products and services including Ansible, Open Graph, Snowflake, and more. Explore BioSerenity's tech stack below.
| BioSerenity Email Formats | Percentage |
| First.Last@bioserenity.com | 96% |
| Last@bioserenity.com | 2% |
| FirstLast@bioserenity.com | 1% |
| Last.First@bioserenity.com | 1% |
Medical Equipment ManufacturingÎle-de-france, France201-500 Employees
BioSerenity develops connected medical solutions to help diagnose and monitor patients with chronic diseases in neurology, sleep disorders and cardiology. We use physiological sensors, an IoT platform, apps and A.I. to detect digital biomarkers. We work with more than 200 hospitals in Europe and help diagnose over a hundred thousand patients per year. Our headquarter is in Paris, France.
Company Overview
Media & News
Funding & FinancialsBioSerenity has raised a total of $26M of funding over 7 rounds. Their latest funding round was raised on Nov 13, 2023 in the amount of $26M.
BioSerenity's revenue is estimated to be in the range of $10M$25M
Funding & FinancialsBioSerenity has raised a total of $26M of funding over 7 rounds. Their latest funding round was raised on Nov 13, 2023 in the amount of $26M.
BioSerenity's revenue is estimated to be in the range of $10M$25M
1-888-653-2347 
support@leadiq.com